Psychedelic Care
The EOLPC Philosophy
EOLPC is deeply committed to helping anyone overcome their fear of dying. At EOLPC, Psychedelic Care is a holistic approach to mental, emotional and spiritual wellbeing for those with life-threatening or terminal illnesses. We see our role as giving you the information to make an informed decision as to whether psychedelic care is right for you then connecting you with support trained in both psychedelic and end-of-life care.
FIVE EXPERTS
Talk Psychedelics for End of Life Care
EOLPC hosted an Open Forum where members of the community came together to ask their questions about the use of psychedelics to help those with life-threatening or terminal illnesses. The questions that arose were wide-ranging and deserve further discussion. EOLPC brought together 5 experts who shared their collective knowledge and experiences to answer as many questions as possible.
EOLPC
EDUCATION COURSES
EOLPC’s goal is to help you make an informed decision. There are many different ways to approach the safe use of psychedelics and our philosophy is to provide the information you need. We do not dictate your decision as it is a very personal one but our emphasis will always be on SAFE use. We welcome all participants who want to learn about psychedelic care, including family members and the community at-large
$0.00
$450.00
$600.00
Coming Soon
Sign Up For Course Announcements
Check out the upcoming courses below and sign up to be notified when registration opens if you aren’t already on our list. CEs are available for nurses, social workers, psychologists and physical therapists, depending on state.
CME Course: Integrating Ketamine Therapy into Palliative Care: Evidence, Protocols, and Practice – Next Cohort – Fall 2026
This four-session CME course is designed for ketamine providers seeking to establish or expand their practice into palliative and end-of-life care. Participants will learn evidence-based approaches to dosing, protocols, patient assessment, and integration while gaining practical guidance on regulatory, legal, and practice management essentials. Taught by experienced clinicians and experts in pharmacology, medicine, nursing, and law, this training equips providers with the knowledge and tools to deliver safe, ethical, and compassionate ketamine care.
Delving Deep into the Medicines: Responsible Dosing for End of LIfe Care – October 2026
One of our most popular courses! When it comes to psychedelic work with those facing the end of life, questions around dosing and stacking often go unanswered. This three-hour workshop offers a practical, in-depth exploration of psychedelic medicine use in end-of-life care. Led by two experienced facilitators, you’ll gain a deeper understanding of psilocybin, ketamine, MDMA, 5-MeO-DMT, and other relevant medicines. Designed for guides, clinicians, and caregivers ready to go beyond the basics, this course will help you dose responsibly, especially when working with the unique complexities of end-of-life care.
Cannabis Therapy for End of Life, Summer 2026
Cannabis at end of life has proven to offer anti-anxiety, inflammatory soothing and sleep enhancing properties. Finding the right strain can take experimentation to elicit response since everyone’s Endocannabinoid system is different and depend on the disease process and metabolism issues. Not only this, but in last days and vigil periods, a little cannabis can also be good for the entire family to accentuate the peace and help create a spiritual cocoon around the patient instead of stress and anxiety. This course will provide a basic tutorial on cannabis and how best to use it in the care for those toward the end of life.
Understanding Grief and Loss for Psychedelic Practitioners: Foundational Concepts and Applications in Individual and Group Work, Winter 2027
This four-session online course begins by building a grounded foundation in understanding grief itself, how it unfolds across the brain, body, relationships, and lived experience, before expanding into applications within psychedelic practice and group work. Through didactic teaching, case discussion, interactive exercises, reflection, and modeled facilitation, participants will have opportunities to connect the material to both their personal experience and professional practice.
iSpiritual Dimensions for Psychedelic Practitioners, Winter 2027,Â
Designed for practitioners working, or seeking to work, at the intersection of psychedelic care, serious illness, and end-of-life support, this 3 session online and interactive course provides a practical foundation in spiritual assessment, meaning-making, and spiritually responsive care. Through teaching, reflection, discussion, and experiential exercises, participants will develop core spiritual care competencies that can be immediately applied within psychedelic, palliative, hospice, and end-of-life settings.
Led by Buddhist chaplain, hospice nurse, and psychedelic facilitator Rhiana Wiggins, this three-session course explores how practitioners can recognize, accompany, and support the spiritual excavation that often unfolds during these profound experiences.
Mindfulness, Microdosing, and Dementia, Winter 2027
As interest in psychedelic medicine continues to grow, questions are emerging about whether carefully designed microdosing approaches may offer meaningful support for people living with cognitive impairment and for the caregivers who walk beside them. This workshop provides a thoughtful, evidence-informed framework for exploring these questions through the combined lenses of mindfulness, compassionate end-of-life care, and practical protocol design.
Led by mindfulness teacher, author, and microdosing educator Lauren Alderfer, this interactive 3 hour workshop combines presentation, experiential learning, guided mindfulness practice, and discussion. Participants will develop a practical understanding of mindfulness as an approach to end-of-life care while learning Lauren’s Microdosing Protocol for individuals with mild to moderate cognitive impairment and her companion Microdosing+ Protocol designed specifically to support caregivers.
THE
PSYCHEDELICS
EOLPC’s educational programs focus primarily on Psilocybin and Ketamine. Psilocybin is the most widely researched psychedelic medicine studied to measure its impact on reducing psychological and existential distress at end of life, as well as to foster spiritual awakening. Ketamine was FDA approved in 1970 and used in surgical procedures, to manage pain, and to reduce mental distress. In one retrospective study, ketamine was shown to be the most like a near death experience which, for many people, helped them overcome their fear of dying.
Psilocybin
Psilocybin is the psychoactive ingredient in “magic mushrooms”. Most people report experiencing mystical consciousness, an indescribable knowing that we all exist as one.
​Psilocybin has been widely researched: for more than two decades, universities such as Johns Hopkins, NYU and UCLA have consistently shown that the use of psilocybin-assisted therapy reduces anxiety and depression in participants with advanced-stage cancer. Not only that, participants also confronted their fear of dying, found meaning in their lives and came to feel at peace with their death and dying.
Psilocybin is just now becoming available across the US. Oregon is the first state to institute Licensed Service Centers, set to open in the Fall of 2023. And there are many jurisdictions around the country that allow for “decriminalized” use, as well as churches where members can participate in spiritual and non-denominational ceremonies.
How psilocybin helped cancer patient Kerry Pappas.
Listen to this short video clip as Anderson Cooper interviews Kerry Pappas about her experience in the Johns Hopkins clinical trial using psilocybin-assisted therapy to reduce her anxiety and come to terms with her cancer diagnosis. Courtesy: CBS 60 Minutes.
Ketamine Therapy
Ketamine was first approved by the FDA in 1970 as an analgesic and sedative for surgery. Doctors began to realize that ketamine had broader potential when surgical patients began reporting that symptoms related to a number of mental disorders were alleviated. Since the 1990s, it has been safely used off-label to treat chronic pain, anxiety, depression, OCD, PTSD, suicidal ideation and more.
Ketamine has also been studied in palliative care patients and, similar to psilocybin, been shown to decrease anxiety and depression. It is different than psilocybin and it may not cause as mystical a journey but ketamine has a special property all its own that separates you from your body and takes you deep into your subconscious for insights and healing.
Although ketamine treatment often requires multiple medicine sessions as compared to psilocybin, it is widely available across North America and one of the safest medicines around.
One Woman's Ketamine Story.
When Cathy P. was first diagnosed with brain cancer 5 years ago, she suffered debilitating and isolating depression. She found her way to Ketamine Therapy and after the first treatment session, she felt the depression lift and after several more, she found herself experiencing joy. She even started working again, something she hadn’t done in more than 4 years. Both she and her husband learned to enjoy life in the present moment.
After a year, though, painful neuropathy and trigeminal neuralgia surfaced. Cathy was maintaining her mental health with Ketamine “boosters” every 8 weeks but now she turned to it to help with the pain. This dose is much higher but it reduced the pain in her feet and along her jaw line, enough so that she could remain at her job. Ketamine became her best weapon now to manage pain with a regimen of IV sessions and lozenges taken at-home to prolong the relief.
